HIGH-RESOLUTION H-1-NMR SPECTROSCOPY STUDIES OF EXTRACTS OF HUMAN CEREBRAL NEOPLASMS

被引:216
作者
PEELING, J
SUTHERLAND, G
机构
[1] UNIV WINNIPEG,DEPT CHEM,WINNIPEG R3B 2E9,MANITOBA,CANADA
[2] UNIV MANITOBA,DEPT RADIOL,WINNIPEG R3A 1R9,MANITOBA,CANADA
[3] UNIV MANITOBA,DEPT SURG NEUROSURG,WINNIPEG R3A 1R9,MANITOBA,CANADA
[4] UNIV MANITOBA,DEPT PHARMACOL & THERAPEUT,WINNIPEG R3A 1R9,MANITOBA,CANADA
关键词
D O I
10.1002/mrm.1910240113
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
High‐resolution 1H NMR spectroscopy has been used to measure the concentrations of metabolites (alanine, N‐acetylaspartate, γ‐aminobutyric acid, glutamate, glutamine, aspartate, taurine, glycine, succinate, creatine, cholines, inositol, and glucose) in perchloric acid extracts of human epileptic cortex and brain tumors. All tissue was obtained by surgical biopsy, excised before thermal coagulation, and immediately frozen in liquid nitrogen. Lower levels of N‐acetylaspartate and γ‐aminobutyric acid and a shift in the glutamate/glutamine ratio toward glutamine in the tumors reflect neuronal loss. Abnormal glucose metabolism (aerobic glycolysis) in the tumors gives decreased levels of succinate, glutamate, aspartate, glutamine, and creatine and generally increased concentrations of glycine and alanine. Differences in metabolite concentrations that may be of use in differential tumor diagnosis include lower creatine and inositol in meningiomas than in astrocytomas. Lower taurine differentiates benign from malignant astrocytomas. Malignant astrocytomas and metastatic tumors are more regionally heterogeneous than meningiomas or benign astrocytomas. Mannitol, administered perioperatively to all patients from whom tissue was obtained, was observed only in the spectra of extracts of tissue from tumors which enhanced on computerized tomographic imaging. © 1992 Academic Press, Inc. Copyright © 1992 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:123 / 136
页数:14
相关论文
共 53 条
  • [1] AISENBERG AC, 1961, GLYCOLYSIS RESPIRATI
  • [2] ALLEN N, 1972, PROG EXP TUMOR RES, V17, P192
  • [3] INVIVO H-1 SPECTROSCOPY IN HUMANS AT 1.5-T
    BARANY, M
    LANGER, BG
    GLICK, RP
    VENKATASUBRAMANIAN, PN
    WILBUR, AC
    SPIGOS, DG
    [J]. RADIOLOGY, 1988, 167 (03) : 839 - 844
  • [4] BATEMAN D E, 1988, Neurological Research, V10, P112
  • [5] NONINVASIVE DIFFERENTIATION OF TUMORS WITH USE OF LOCALIZED H-1 MR SPECTROSCOPY INVIVO - INITIAL EXPERIENCE IN PATIENTS WITH CEREBRAL-TUMORS
    BRUHN, H
    FRAHM, J
    GYNGELL, ML
    MERBOLDT, KD
    HANICKE, W
    SAUTER, R
    HAMBURGER, C
    [J]. RADIOLOGY, 1989, 172 (02) : 541 - 548
  • [6] H-1-NMR DETECTION OF CEREBRAL MYOINOSITOL
    CERDAN, S
    PARRILLA, R
    SANTORO, J
    RICO, M
    [J]. FEBS LETTERS, 1985, 187 (01) : 167 - 172
  • [7] COMBINED USE OF H-1-NMR AND GC-MS FOR METABOLITE MONITORING AND INVIVO H-1-NMR ASSIGNMENTS
    FAN, TWM
    HIGASHI, RM
    LANE, AN
    JARDETZKY, O
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 882 (02) : 154 - 167
  • [8] GEDER L, 1989, Neurofibromatosis, V2, P23
  • [9] Gill S S, 1989, NMR Biomed, V2, P196, DOI 10.1002/nbm.1940020505
  • [10] PROTON MR SPECTROSCOPY OF INTRACRANIAL TUMORS - INVIVO AND INVITRO STUDIES
    GILL, SS
    THOMAS, DGT
    VANBRUGGEN, N
    GADIAN, DG
    PEDEN, CJ
    BELL, JD
    COX, IJ
    MENON, DK
    ILES, RA
    BRYANT, DJ
    COUTTS, GA
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1990, 14 (04) : 497 - 504